Abstract:MicroRNAs (miRNAs) are evolutionarily conserved small non-protein coding RNA transcripts that, typically, negatively regulate gene expression at a post-transcriptional level. miRNAs exert these effects on diverse physiological functions in development and homeostasis in a variety of organisms including Homo sapiens. Deregulation of endogenous miRNAs has been found in the pathogenesis of diseases, particularly in cancer. Extensive miRNAs-association studies in cancer have characterized unique 'oncomiRs' (e.g. miR-21, miR-155, miR-17-92 and C19MC miRNAs), 'TS-miRNAs' (tumor suppressor miRNAs e.g. miR-15a/16-1, let-7), 'metasta-miRNAs' (metastasis regulatory miRNAs e.g. miR-10a, miR-34) and 'epi-miRNAs' (epigenetically regulated miRNAs e.g. miR-29a/b/c) in cancer development, progression and metastasis. These findings have inspired the cancer research community to utilize "fingerprint-miRNAs" to aid in cancer diagnosis and prognosis and it has emerged as an exciting new approaches for potential alternative cancer therapy. Restoration of miRNAs in cancer cells with either miRNA mimics or antagomiRs has demonstrated an effective approach to change the cancer cell fate in numerous cultured systems and a few animal models. Due to the nature of miRNAs targeting multiple genes and miRNA-transcription factor co-regulation of gene expression networks, modulation of one or a subgroup of miRNAs could reprogram whole regulatory networks as reflected in multiple core pathways, such as proliferation and apoptosis, differentiation, cell adhesion and invasion as well as epigenomic and genomic stability. In this chapter, we will discuss the miRNA regulation in the genome, highlight the progress of miRNA-based exploratory cancer treatment, and underscore the challenges of developing "miRNA-drugs" with network perturbation.

Post-transcription regulation of drug metabolic enzymes by miRNAs

MicroRNA: A New Mechanism for Regulation of Mitochondrial Function

Research status of microRNA mediated drug regulation of transporter and metabolizing enzymes

Development of Microrna-Dependent Control of Cytochrome P450

Small-Molecule Regulators of MicroRNAs in Biomedicine.

MiRNAs and Mirna Polymorphisms Modify Drug Response

Small Molecules Modulating Biogenesis or Processing of microRNAs with Therapeutic Potentials

MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms Behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Efflux ABC transporters in drug disposition and their posttranscriptional gene regulation by microRNAs

MiRNA and interindividual difference in drug response

The Effects of Microrna on the Absorption, Distribution, Metabolism and Excretion of Drugs

MicroRNA-based Therapeutic Technologies

Research status of microRNA-dependent control of drug metabolic enzymes and transporters mediated by nuclear receptors

Bioengineered Mir-27B-3p and Mir-328-3p Modulate Drug Metabolism and Disposition Via the Regulation of Target ADME Gene Expression.

Transcriptional and epigenetic regulation of human microRNAs.

MicroRNA and metabolism regulation]

Post-transcriptional regulation of miRNA biogenesis and functions

A Decade’s Review of Mirna: A Center of Transcriptional Regulation of Drugmetabolizing Enzymes and Transporters under Hypoxia

Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research

Progress in study on single nucleotide polymorphism in microRNA target sites and cancer as well as drug susceptibility

Regulation Of Micrornas For Potential Cancer Therapeutics: The Paradigm Shift From Pathways To Perturbation Of Gene Regulatory Networks